drugset / Trial / NCT00621218
A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the efficacy and safety of tretinoin gel 0.05% to its vehicle when dosed once or twice daily in female subjects with rosacea.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-04
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tretinoin | Small molecule | 0.05 % | Topical |